MicroRNA-29a May Influence Myopia Development by Regulating Collagen I.

Area of Science:

• Ophthalmology
• Molecular Biology
• Genetics

Background:

• Myopia, a common vision disorder, poses a significant public health challenge.
• Understanding the molecular mechanisms underlying myopia progression is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the regulatory role of microRNA-29a (miR-29a) in the development of human myopia.
• To explore miR-29a as a potential biomarker and therapeutic target for myopia.

Main Methods:

• Quantitative polymerase chain reaction (qPCR) was used to measure miR-29a expression in aqueous humor and blood plasma of myopia patients and controls.
• iTRAQ proteomic analysis was performed on human scleral fibroblasts (SFs) to assess miR-29a's regulatory effects.
• SF cell proliferation, migration, and collagen I synthesis were evaluated in vitro.

Main Results:

• miR-29a expression was significantly elevated in the aqueous humor of high myopia patients compared to controls (fold change: 4.861, p = 0.001).
• In vitro studies showed that miR-29a inhibited type I collagen synthesis in human SFs and enhanced cell migration.
• miR-29a did not significantly affect SF cell proliferation.

Conclusions:

• Elevated miR-29a levels in the aqueous humor of myopia patients suggest its involvement in the disease.
• The inhibition of collagen I synthesis by miR-29a in SFs indicates a potential mechanism for myopia development.
• miR-29a presents a promising target for future myopia therapies.